These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 34326906)

  • 21. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?
    Malik AN; Czajka A
    Mitochondrion; 2013 Sep; 13(5):481-92. PubMed ID: 23085537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can Mitochondria DNA Provide a Novel Biomarker for Evaluating the Risk and Prognosis of Colorectal Cancer?
    Shuwen H; Xi Y; Yuefen P
    Dis Markers; 2017; 2017():5189803. PubMed ID: 28408773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial dysfunction and cancer metastasis.
    Chen EI
    J Bioenerg Biomembr; 2012 Dec; 44(6):619-22. PubMed ID: 22892817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic insights into OXPHOS defect and its role in cancer.
    Chandra D; Singh KK
    Biochim Biophys Acta; 2011 Jun; 1807(6):620-5. PubMed ID: 21074512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial DNA and carcinogenesis (review).
    Grzybowska-Szatkowska L; Slaska B
    Mol Med Rep; 2012 Nov; 6(5):923-30. PubMed ID: 22895648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding Mitochondrial Polymorphisms in Cancer.
    Bussard KM; Siracusa LD
    Cancer Res; 2017 Nov; 77(22):6051-6059. PubMed ID: 29097610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer.
    Balachander K; Roy A; Priyadharsini JV; Murugan S; Paramasivam A
    Oral Oncol; 2022 May; 128():105857. PubMed ID: 35421822
    [No Abstract]   [Full Text] [Related]  

  • 28. Progress on the Physiological Function of Mitochondrial DNA and Its Specific Detection and Therapy.
    Zhang C; Xue Y; Wang L; Wu Q; Fang B; Sheng Y; Bai H; Peng B; Yang N; Li L
    Chembiochem; 2022 Feb; 23(4):e202100474. PubMed ID: 34661371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress-related mitochondrial components and mitochondrial genome as targets of anticancer therapy.
    Giannattasio S; Guaragnella N; Arbini AA; Moro L
    Chem Biol Drug Des; 2013 Jan; 81(1):102-12. PubMed ID: 23253132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma.
    Hsu CC; Lee HC; Wei YH
    World J Gastroenterol; 2013 Dec; 19(47):8880-6. PubMed ID: 24379611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial DNA levels in blood and tissue samples from breast cancer patients of different stages.
    Xia P; Wang HJ; Geng TT; Xun XJ; Zhou WJ; Jin TB; Chen C
    Asian Pac J Cancer Prev; 2014; 15(3):1339-44. PubMed ID: 24606462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential.
    Wagner A; Kosnacova H; Chovanec M; Jurkovicova D
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic alterations in mitochondrial DNA and mitochondrial dysfunction in gastric cancer progression.
    Lee HC; Huang KH; Yeh TS; Chi CW
    World J Gastroenterol; 2014 Apr; 20(14):3950-9. PubMed ID: 24744584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.
    Hatakeyama H; Goto Y
    Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defects of intergenomic communication: where do we stand?
    Hirano M; Vu TH
    Brain Pathol; 2000 Jul; 10(3):451-61. PubMed ID: 10885664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of potential cancer biomarkers in mitochondrial DNA.
    Jakupciak JP; Dakubo GD; Maragh S; Parr RL
    Curr Opin Mol Ther; 2006 Dec; 8(6):500-6. PubMed ID: 17243485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation, function and diagnostic value of mitochondrial DNA copy number alterations in human cancers.
    Yu M
    Life Sci; 2011 Jul; 89(3-4):65-71. PubMed ID: 21683715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer.
    Kulawiec M; Salk JJ; Ericson NG; Wanagat J; Bielas JH
    Environ Mol Mutagen; 2010 Jun; 51(5):427-39. PubMed ID: 20544883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular oncology focus - is carcinogenesis a 'mitochondriopathy'?
    Czarnecka AM; Czarnecki JS; Kukwa W; Cappello F; Scińska A; Kukwa A
    J Biomed Sci; 2010 Apr; 17(1):31. PubMed ID: 20416110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1-mediated immunoescape via STING-IFN signaling and extracellular vesicles.
    Cheng AN; Cheng LC; Kuo CL; Lo YK; Chou HY; Chen CH; Wang YH; Chuang TH; Cheng SJ; Lee AY
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33268351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.